Engineered cell membrane-based nano therapies fight infectious diseases

Area of Science:

• Biotechnology and Nanomedicine
• Infectious Disease Therapeutics
• Drug Delivery Systems

Background:

• Infectious diseases remain a major global health concern, driven by pathogens like bacteria and viruses.
• Conventional treatments are hampered by drug resistance, poor targeting, and adverse effects.
• Cell membrane vesicles (MVs) show promise as biocompatible drug carriers for infectious disease treatment.

Purpose of the Study:

• To provide a comprehensive overview of engineered membrane vesicles (EMVs) for infectious disease therapy.
• To detail the production and modification techniques of MVs for enhanced functionality.
• To critically analyze the clinical prospects and challenges of EMVs in combating infectious diseases.

Main Methods:

• Review of current literature on MV production and engineering strategies.
• Analysis of advancements in modifying MVs for improved drug delivery and therapeutic efficacy.
• Critical evaluation of clinical translation data and challenges for EMVs.

Main Results:

• Engineered membrane vesicles (EMVs) demonstrate significant potential as versatile nanoplatforms.
• Modification techniques enhance MV functionality for targeted delivery and efficacy against pathogens.
• EMVs offer a promising alternative to conventional therapies for infectious diseases.

Conclusions:

• EMVs represent a cutting-edge approach to overcoming limitations in infectious disease treatment.
• Further research and development are needed to address existing challenges for clinical translation.
• Recommendations are proposed to guide future studies towards practical EMV applications.